Faika Mseeh

2.9k total citations
19 papers, 1.1k citations indexed

About

Faika Mseeh is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Faika Mseeh has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Molecular Biology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Faika Mseeh's work include Pancreatic function and diabetes (9 papers), Diabetes Treatment and Management (8 papers) and Mast cells and histamine (3 papers). Faika Mseeh is often cited by papers focused on Pancreatic function and diabetes (9 papers), Diabetes Treatment and Management (8 papers) and Mast cells and histamine (3 papers). Faika Mseeh collaborates with scholars based in United States and Germany. Faika Mseeh's co-authors include David R. Powell, Melanie K. Shadoan, Brian Zambrowicz, Arthur Sands, Zhi‐Ming Ding, Melinda Smith, Christopher M. DaCosta, Andrei L. Osterman, Jennifer Greer and Angela L. Harris and has published in prestigious journals such as Blood, Journal of Bacteriology and Pain.

In The Last Decade

Faika Mseeh

17 papers receiving 1.1k citations

Peers

Faika Mseeh
Xiaolan Shen United States
Manuel Grundmann Germany
Diane M. Hargrove United States
Attilio Pingitore Italy
J. Boyer France
T. Hirose Japan
Aine McKillop United Kingdom
Michael Chvanov United Kingdom
Laura Revel Italy
T.G. Flynn Canada
Xiaolan Shen United States
Faika Mseeh
Citations per year, relative to Faika Mseeh Faika Mseeh (= 1×) peers Xiaolan Shen

Countries citing papers authored by Faika Mseeh

Since Specialization
Citations

This map shows the geographic impact of Faika Mseeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faika Mseeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faika Mseeh more than expected).

Fields of papers citing papers by Faika Mseeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faika Mseeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faika Mseeh. The network helps show where Faika Mseeh may publish in the future.

Co-authorship network of co-authors of Faika Mseeh

This figure shows the co-authorship network connecting the top 25 collaborators of Faika Mseeh. A scholar is included among the top collaborators of Faika Mseeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faika Mseeh. Faika Mseeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Stice, James P., Yuting Sun, Nancy E. Kohl, et al.. (2021). Abstract P207: BBP-398, a potent, small molecule inhibitor of SHP2, enhances the response of established NSCLC xenografts to KRASG12C and mutEGFR inhibitors. Molecular Cancer Therapeutics. 20(12_Supplement). P207–P207. 8 indexed citations
3.
Ma, Jiacheng, Paul Acton, Virginie Buggia-Prévot, et al.. (2021). Inhibition of dual leucine zipper kinase prevents chemotherapy-induced peripheral neuropathy and cognitive impairments. Pain. 162(10). 2599–2612. 16 indexed citations
4.
Powell, David R., Melinda Smith, Deon Doree, et al.. (2017). LX2761, a Sodium/Glucose Cotransporter 1 Inhibitor Restricted to the Intestine, Improves Glycemic Control in Mice. Journal of Pharmacology and Experimental Therapeutics. 362(1). 85–97. 25 indexed citations
5.
Goodwin, Nicole C., Zhi‐Ming Ding, Bryce A. Harrison, et al.. (2017). Discovery of LX2761, a Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitor Restricted to the Intestinal Lumen, for the Treatment of Diabetes. Journal of Medicinal Chemistry. 60(2). 710–721. 57 indexed citations
6.
Petrocchi, Alessia, Elisabetta Leo, Matthew M. Hamilton, et al.. (2016). Identification of potent and selective MTH1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(6). 1503–1507. 52 indexed citations
7.
Powell, David R., Melinda Smith, Deon Doree, et al.. (2015). LP‐925219 maximizes urinary glucose excretion in mice by inhibiting both renal SGLT1 and SGLT2. Pharmacology Research & Perspectives. 3(2). e00129–e00129. 10 indexed citations
8.
Powell, David R., Christopher M. DaCosta, Melinda Smith, et al.. (2014). Effect of LX4211 on Glucose Homeostasis and Body Composition in Preclinical Models. Journal of Pharmacology and Experimental Therapeutics. 350(2). 232–242. 44 indexed citations
9.
Powell, David R., Melinda Smith, Jennifer Greer, et al.. (2013). LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose. Journal of Pharmacology and Experimental Therapeutics. 345(2). 250–259. 156 indexed citations
10.
Blat, Yuval, Barbara Robertson, Bradley C. Pearce, et al.. (2013). Identification of Small Molecules That Selectively Inhibit Diacylglycerol Lipase–α Activity. SLAS DISCOVERY. 19(4). 595–605. 15 indexed citations
11.
Zambrowicz, Brian, J Freiman, Phil Brown, et al.. (2012). LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial. Clinical Pharmacology & Therapeutics. 92(2). 158–169. 202 indexed citations
12.
Powell, David R., Christopher M. DaCosta, Jason Gay, et al.. (2012). Improved glycemic control in mice lacking Sglt1 and Sglt2. American Journal of Physiology-Endocrinology and Metabolism. 304(2). E117–E130. 130 indexed citations
13.
14.
Goodwin, Nicole C., Ross Mabon, Bryce A. Harrison, et al.. (2009). Novel l-Xylose Derivatives as Selective Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes. Journal of Medicinal Chemistry. 52(20). 6201–6204. 63 indexed citations
15.
Gerdin, Matthew J., Faika Mseeh, & Margarita L. Dubocovich. (2003). Mutagenesis studies of the human MT2 melatonin receptor. Biochemical Pharmacology. 66(2). 315–320. 34 indexed citations
16.
Karthikeyan, S., Qingxian Zhou, Faika Mseeh, et al.. (2003). Crystal Structure of Human Riboflavin Kinase Reveals a β Barrel Fold and a Novel Active Site Arch. Structure. 11(3). 265–273. 66 indexed citations
17.
Mseeh, Faika, Matthew J. Gerdin, & M. L. Dubocovich. (2002). Identification of cysteines involved in ligand binding to the human melatonin MT2 receptor. European Journal of Pharmacology. 449(1-2). 29–38. 18 indexed citations
18.
Gerdes, Svetlana, Michael D. Scholle, Mark D’Souza, et al.. (2002). From Genetic Footprinting to Antimicrobial Drug Targets: Examples in Cofactor Biosynthetic Pathways. Journal of Bacteriology. 184(16). 4555–4572. 236 indexed citations
19.
Mseeh, Faika, Roberta F. Colman, & R W Colman. (2000). Inactivation of Platelet PDE2 by an Affinity Label. Thrombosis Research. 98(5). 395–401. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaolan Shen Breakdown of academic impact, for papers by Manuel Grundmann Breakdown of academic impact, for papers by Diane M. Hargrove Breakdown of academic impact, for papers by Attilio Pingitore Breakdown of academic impact, for papers by J. Boyer Breakdown of academic impact, for papers by T. Hirose Breakdown of academic impact, for papers by Aine McKillop Breakdown of academic impact, for papers by Michael Chvanov Breakdown of academic impact, for papers by Laura Revel Breakdown of academic impact, for papers by T.G. Flynn
Rankless by CCL
2026